Journal list menu
Export Citations
Download PDFs
ISSUE INFORMATION
META-ANALYSIS
Meta-analysis: The efficacy of therapeutic drug monitoring of anti-TNF-therapy in inflammatory bowel disease
- Pages: 1362-1374
- First Published: 09 December 2022

A systematic review and meta-analysis on the efficacy of therapeutic drug monitoring (TDM) of anti TNF-therapyin inflammatory bowel disease shows several benefits in using proactive TDM. Proactive TDM was associated with reducing treatment failure when compared to standard of care and reactive TDM. It also led to reduced surgical rates, improved clinical and endoscopic remission and response compared to standardof care.
REVIEW ARTICLE
Review article: Functional dyspepsia and pregnancy—Effects and management in a special population
- Pages: 1375-1396
- First Published: 02 May 2023
ACUTE KIDNEY INJURY IN CIRRHOSIS
Longer time to recovery from acute kidney injury is associated with major adverse kidney events in patients with cirrhosis
- Pages: 1397-1406
- First Published: 07 March 2023
LONG-TERM ENDOSCOPIC SURVEILLANCE IN HBV CIRRHOSIS ON TENOFOVIR OR ENTECAVIR
Long-term endoscopic surveillance in HBV compensated cirrhotic patients treated with Tenofovir or Entecavir for 11 years
- Pages: 1407-1416
- First Published: 28 March 2023
ELF AND FIB-4 SCORES TO DETECT SIGNIFICANT FIBROSIS IN NAFLD
The combination of the enhanced liver fibrosis and FIB-4 scores to determine significant fibrosis in patients with nonalcoholic fatty liver disease
- Pages: 1417-1422
- First Published: 26 March 2023
ASSOCIATION BETWEEN TYPE 1 DIABETES AND MICROSCOPIC COLITIS IN SWEDEN
Type 1 diabetes and microscopic colitis: A nationwide matched case–control study in Sweden
- Pages: 1423-1431
- First Published: 22 March 2023
CLINICAL SIGNIFICANCE OF GASTRIC NON-HELICOBACTER PYLORI HELICOBACTER SPECIES
Clinical significance and impact of gastric non-Helicobacter pylori Helicobacter species in gastric disease
- Pages: 1432-1444
- First Published: 28 March 2023
RISK OF COLORECTAL NEOPLASIA BY HISTOLOGIC DISEASE ACTIVITY IN IBD
Risk of colorectal neoplasia according to histologic disease activity in patients with inflammatory bowel disease and colonic post-inflammatory polyps
- Pages: 1445-1452
- First Published: 31 March 2023
INVITED EDITORIALS
Editorial: proactive anti-TNF drug monitoring in IBD—Ready for prime time?
- Pages: 1453-1454
- First Published: 27 May 2023
This article is linked to Sethi et al papers. To view these articles, visit https://doi.org/10.1111/apt.17313 and https://doi.org/10.1111/apt.17339
Editorial: proactive anti-TNF drug monitoring in IBD—Ready for the prime time? Authors' reply
- Pages: 1455-1456
- First Published: 27 May 2023
This article is linked to Sethi et al papers. To view these articles, visit https://doi.org/10.1111/apt.17313 and https://doi.org/10.1111/apt.17333
Editorial: type 1 diabetes, microscopic colitis and the need to explore the complex mechanisms of this association
- Pages: 1457-1458
- First Published: 27 May 2023
This article is linked to Kang et al. papers. To view these articles, visit https://doi.org/10.1111/apt.17473 and https://doi.org/10.1111/apt.17518
Editorial: type 1 diabetes, microscopic colitis and the need to explore the complex mechanisms of this association—authors' reply
- Pages: 1459-1460
- First Published: 27 May 2023
This article is linked to Kang et al papers. To view these articles, visit https://doi.org/10.1111/apt.17473 and https://doi.org/10.1111/apt.17501
Editorial: optimal combination of non-invasive tests to determine significant fibrosis in non-alcoholic fatty liver disease
- Pages: 1461-1462
- First Published: 27 May 2023
This article is linked to Younossi et al papers. To view these articles, visit https://doi.org/10.1111/apt.17472 and https://doi.org/10.1111/apt.17517
Editorial: optimal combination of non-invasive tests to determine significant fibrosis in non-alcoholic fatty liver disease—authors' reply
- Pages: 1463-1464
- First Published: 27 May 2023
This article is linked to Younossi et al papers. To view these articles, visit https://doi.org/10.1111/apt.17472 and https://doi.org/10.1111/apt.17505
Editorial: the other bug
- Pages: 1465-1466
- First Published: 27 May 2023
This article is linked to Taillieu et al paper. To view this article, visit https://doi.org/10.1111/apt.17488
Editorial: in the era of effective antiviral therapy, long-term dynamic endoscopic monitoring does not seem to be necessary for all CHB patients with compensated cirrhosis
- Pages: 1467-1468
- First Published: 27 May 2023
This article is linked to Farina et al paper. To view this article, visit https://doi.org/10.1111/apt.17463
Editorial: golimumab dosing intensification effective in ulcerative colitis with no need for therapeutic drug monitoring
- Pages: 1469-1470
- First Published: 27 May 2023
This article is linked to Fumery et al papers. To view these articles, visit https://doi.org/10.1111//apt.17421 and https://doi.org/10.1111/apt.17514
Editorial: golimumab dosing intensification effective in ulcerative colitis with no need for therapeutic drug monitoring—author's reply
- Pages: 1471-1472
- First Published: 27 May 2023
This article is linked to Fumery et al papers. To view these articles, visit https://doi.org/10.1111//apt.17421 and https://doi.org/10.1111/apt.17439
Editorial: composite kidney outcomes in studies with patients with cirrhosis and AKI—Are we ready to “MAKE” the switch?
- Pages: 1473-1474
- First Published: 27 May 2023
This article is linked to Patidar et al paper. To view this article, visit https://doi.org/10.1111/apt.17457
LETTERS TO THE EDITORS
Letter: practical considerations for nonselective beta-blocker therapy in portal hypertension
- Pages: 1475-1476
- First Published: 27 May 2023
This article is linked to Gillespie et al paper. To view this article, visit https://doi.org/10.1111/apt.17380
Letter: delays to diagnosis of IBD—Challenges requiring a systematic approach
- Pages: 1477-1478
- First Published: 27 May 2023
This article is linked to Jayasooriya et al papers. To view these articles, visit https://doi.org/10.1111/apt.17370 and https://doi.org/10.1111/apt.17548
Letter: delays to diagnosis of IBD—Challenges requiring a systematic approach. Authors’ reply
- Page: 1479
- First Published: 27 May 2023
This article is linked to Jayasooriya et al papers. To view these articles, visit https://doi.org/10.1111/apt.17370 and https://doi.org/10.1111/apt.17521
Letter: histologic disease activity and colorectal neoplasia risk
- Page: 1480
- First Published: 27 May 2023
This article is linked to Wolf et al papers. To view these articles, visit https://doi.org/10.1111/apt.17495 and https://doi.org/10.1111/apt.17536
Letter: histologic disease activity and colorectal neoplasia risk—authors' reply
- Page: 1481
- First Published: 27 May 2023
This article is linked to Wolf et al papers. To view these articles, visit https://doi.org/10.1111/apt.17495 and https://doi.org/10.1111/apt.17528
Letter: Albumin—Does formulation matter?
- Pages: 1482-1483
- First Published: 27 May 2023
This article is linked to Leache et al papers. To view these articles, visit https://doi.org/10.1111/apt.17344 and https://doi.org/10.1111/apt.17546
Letter: Albumin—Does formulation matter? Authors' reply
- Pages: 1484-1485
- First Published: 27 May 2023
This article is linked to Leache et al papers. To view these articles, visit https://doi.org/10.1111/apt.17344 and https://doi.org/10.1111/apt.17531